scholarly article | Q13442814 |
P50 | author | Ravinder Anand-Ivell | Q58216532 |
Vivian Kafantaris | Q89169912 | ||
Robert L Findling | Q90314248 | ||
Jean A Frazier | Q91815411 | ||
Melissa P DelBello | Q91939875 | ||
Traci E Clemons | Q92993074 | ||
Mani N Pavuluri | Q97868288 | ||
Robert A Kowatch | Q105682862 | ||
Brieana M Rowles | Q114735116 | ||
Nora K McNamara | Q114735127 | ||
Jacqui Lingler | Q114735130 | ||
Perdita Taylor-Zapata | Q114735146 | ||
Russell Scheffer | Q114735153 | ||
Moira Rynn | Q114735154 | ||
Karen Martz | Q114735155 | ||
P2093 | author name string | Adelaide Robb | |
P2860 | cites work | Meta-analysis of epidemiologic studies of pediatric bipolar disorder | Q28240676 |
Lithium salts in the treatment of psychotic excitement | Q28262417 | ||
A children's global assessment scale (CGAS) | Q28271291 | ||
Treatment of bipolar disorder | Q28290437 | ||
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 | ||
A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). | Q30925648 | ||
Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials | Q33975437 | ||
First-dose pharmacokinetics of lithium carbonate in children and adolescents | Q34257156 | ||
Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder | Q35036780 | ||
Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients | Q35698752 | ||
Pediatric versus adult drug trials for conditions with high pediatric disease burden | Q36128904 | ||
Maintenance therapies in bipolar disorder: focus on randomized controlled trials | Q36210974 | ||
A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents | Q36635790 | ||
Predictors of prospectively examined suicide attempts among youth with bipolar disorder | Q36694115 | ||
The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation | Q36865365 | ||
Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode | Q37030962 | ||
Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions | Q37079955 | ||
Factors in the assessment of suicidality in youth | Q37182942 | ||
Psychosocial functioning among bipolar youth | Q37258727 | ||
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study | Q38377712 | ||
Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial | Q38455853 | ||
Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study | Q43258937 | ||
Phenomenology of children and adolescents with bipolar spectrum disorders | Q44270072 | ||
Olanzapine versus placebo in the treatment of adolescents with bipolar mania | Q46979845 | ||
A rating scale for extrapyramidal side effects | Q53780342 | ||
Preliminary studies of the reliability and validity of the children's depression rating scale | Q71328354 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | placebo | Q269829 |
bipolar I disorder | Q4915474 | ||
P304 | page(s) | 885-894 | |
P577 | publication date | 2015-10-12 | |
P1433 | published in | Pediatrics | Q7159238 |
P1476 | title | Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study | |
P478 | volume | 136 |
Q89885050 | An Adolescent Female with Bipolar Disorder Presenting with Lithium-Induced Hyperthyroidism |
Q88536818 | Autoimmune Thyroiditis in an Adolescent Girl on Lithium |
Q52656684 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. |
Q47745367 | Changes in white matter microstructure predict lithium response in adolescents with bipolar disorder. |
Q59813019 | Lithium Treatment Is Safe in Children With Intellectual Disability |
Q95840818 | Lithium Treatment Over the Lifespan in Bipolar Disorders |
Q42944587 | Lithium is Clearly Underutilized in Child Psychiatry |
Q58698888 | Lithium treatment in bipolar adolescents: a follow-up naturalistic study |
Q38859885 | Managing comorbid obesity and depression through clinical pharmacotherapies |
Q39285492 | Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder. |
Q47284608 | Putative mechanisms of action and clinical use of lithium in children and adolescents: a critical review. |
Q47114336 | The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research. |
Q47750180 | The New News about Lithium: An Underutilized Treatment in the United States |
Q55032553 | Treatment-Emergent Mania in a Prepubertal Boy. |
Q52322766 | Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations. |
Search more.